Forskning
Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital
Udgivet

Effect of liraglutide on body weight and microvascular function in non-diabetic overweight women with coronary microvascular dysfunction

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Early diastolic strain rate in relation to long term prognosis following isolated coronary artery bypass grafting

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Association between the E-wave propagation index and left ventricular thrombus formation after ST-elevation myocardial infarction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Right atrial strain: Tapping into a new reservoir of hemodynamic information

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  4. Looking beyond antiplatelet effect of P2Y12 inhibitors: is there anything to see?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Infarct size following loading with Ticagrelor/Prasugrel versus Clopidogrel in ST-segment elevation myocardial infarction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Social inequality in tooth loss: separate and joint effects of household income and dental visits

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Association of fatal myocardial infarction with past level of physical activity: a pooled analysis of cohort studies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Proteoglycan Remodeling Is Accelerated in Females with Angina Pectoris and Diffuse Myocardial Fibrosis: the iPOWER Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Coronary Microvascular Dysfunction: A Practical Approach to Diagnosis and Management

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

BACKGROUND: Coronary microvascular dysfunction (CMD) is associated with adverse cardiovascular outcomes and CMD is a hallmark of type 2 diabetes. Liraglutide improves cardiovascular prognosis through partly unknown mechanisms. We hypothesized that treatment with liraglutide improves CMD and symptoms through weight loss, in non-diabetic overweight patients with angina and no obstructive coronary artery disease (CAD).

METHODS: We included 33 non-diabetic overweight women (BMI > 25) with CMD (Coronary flow velocity reserve (CFVR) ≤2.5), angina symptoms and no obstructive CAD, in an open-label proof-of-concept study. The protocol included a control period of 5 weeks followed by an intervention period with liraglutide aiming at 3 mg daily for 12 weeks. Participants were investigated before and after the control period and again 1-2 weeks after last liraglutide dose. Primary outcomes were change in CFVR and change in angina symptoms measured by the Seattle Angina Questionnaire (SAQ) in the intervention period compared with the control period. (clinicaltrials.gov, NCT02602600, and ethically approved).

RESULTS: Twenty-nine participants completed the study. Liraglutide treatment led to a significant weight loss (mean 6.03 kg (95%CI: 5.22;6.84)) and decrease in systolic blood pressure (mean 10.95 mm Hg (95%CI: 4.60;17.30)). Baseline median CFVR was 2.30 (IQR 1.91;2.51) and remained unchanged after liraglutide treatment (mean change 0.07 (95%CI: -0.07;0.21)). There were no effects on symptoms measured by SAQ or parameters of left ventricular systolic as well as diastolic function.

CONCLUSIONS: Treatment with liraglutide led to significant weight loss and lowering of blood pressure with no concomitant symptoms alleviation during treatment and no improvement in coronary microvascular function.

OriginalsprogEngelsk
TidsskriftInternational Journal of Cardiology
Vol/bind283
Sider (fra-til)28-34
Antal sider7
ISSN0167-5273
DOI
StatusUdgivet - 15 maj 2019

ID: 56740416